Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CTABF CANNTAB THERAPEUTICS LIMITED

0.0950.0000.00%
Close 09/29 16:00 ET
High
0.000
Open
0.095
Turnover
0.00
Low
0.000
Pre Close
0.095
Volume
0.00
Market Cap
3.67M
P/E(TTM)
Loss
52wk High
0.612
Shares
38.87M
P/E(Static)
Loss
52wk Low
0.095
Float Cap
3.67M
Bid/Ask %
0.00%
Historical High
0.854
Shs Float
38.87M
Volume Ratio
0.00
Historical Low
0.095
Dividend TTM
--
Div Yield TTM
--
P/B
4.73
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Float Cap
3.67M
Bid/Ask %
0.00%
Historical High
0.854
Shs Float
38.87M
Volume Ratio
0.00
Historical Low
0.095
Dividend TTM
--
P/B
4.73
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Canntab Therapeutics Ltd. is a biopharmaceutical company. It engages in the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The firm's products include nanoemulsion technology, multi-particulate drug delivery systems, specialty gel capsules, propriety granulation technology, oral quick dissolve tablet, instant release solid oral, extended release solid oral, and bi-layer solid oral. The company was founded by Richard Goldstein and Jeffrey W. Renwick on May 31, 2010 and is headquartered in Markham, Canada.
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...